Evidence map›Paper›PMID 35408548›Full record

ReviewMolecules (Basel, Switzerland)2022

Insight on Mercapto-Coumarins: Synthesis and Reactivity.

Eslam Reda El-Sawy, Ahmed Bakr Abdelwahab, Gilbert Kirsch

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Carbohydrate Chemistry II.Molecules (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Biocatalytic Synthesis of CoumarinMolecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Eslam Reda El-SawyNational Research Centre, Chemistry of Natural Compounds Department, Dokki, Cairo 12622, Egypt.ORCID 0000-0002-7505-3356
Ahmed Bakr AbdelwahabPlant Advanced Technologies (PAT), 54500 Vandœuvre-lès-Nancy, France.ORCID 0000-0002-3949-4189
Gilbert KirschLaboratoire Lorrain de Chimie Moleculaire (L.2.C.M.), Universite de Lorraine, 57050 Metz, France.ORCID 0000-0001-8500-1755
Laboratoire de Chimie Moléculaire · FRNational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mercapto (or sulfanyl)-coumarins are heterocycles of great interest in the development of valuable active structures in material and biological domains. They represent a highly exploitable class of compounds that open many possibilities for further chemical transformations. The present review aims to draw focus toward the synthetic applicability of various forms of mercapto-coumarins and their representations in pharmaceuticals and industries. This work covers the literature issued from 1970 to 2021.

Indexed as

AntioxidantsCoumarinsAntioxidantsCoumarinsbiological activitydiazosulfurationfluorescencemercapto-coumarinsNewman–Kwart

Identifiers

PMID35408548
PMCPMC9000435
OpenAlexW4220786147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.